Acadian Asset Management »

Enliven Therapeutics shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $46k 1.8k 25.21

More positions owned by Acadian Asset Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Check Point Software Tech Ord (CHKP)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Logitech Intl S A SHS (LOGI)
Colgate-Palmolive Company (CL)
Spotify Technology S A SHS (SPOT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Booking Holdings (BKNG)
Cintas Corporation (CTAS)
Marsh & McLennan Companies (MMC)
Wix SHS (WIX)
NetApp (NTAP)

View all positions for Acadian Asset Management

Top funds holding Enliven Therapeutics

OrbiMed Advisors
Commodore Capital
VR Adviser
Fairmount Funds Management
BlackRock
BlackRock
Vanguard Group
5AM Venture Management
Citadel Advisors
RA Capital Management
Pictet Asset Management Holding SA
Woodline Partners
Soleus Capital Management
Geode Capital Management
Henderson Group

View all funds holding Enliven Therapeutics